Dr John Marshall, Dr Johanna Bendell, and Dr Tanios Bekaii-Saab discuss recent data on colorectal cancer presented during ASCO-GI 2018. They examine clinical trial outcomes of targeted therapies and combination therapies, and discuss the role of genomic profiling and the impact of tumor sidedness.